References
- Ruiz CC, Molina-Bolivar JA, Aguilar J, MacIsaac G, Moroze S, Palepu R. Effect of ethylene glycol on the thermodynamic and micellar properties of Tween 20. Colloid Polymer Polym. Sci. 281, 531–541 (2003).
- Robson RJ, Dennis EA. The size, shape, and hydration of nonionic surfactant micelles. Triton X-100. J. Phys. Chem. 81, 1075–1078 (1977).
- Hjelmeland LM, Chrambach A. Electrophoresis and electrofocusing in detergent containing media: a discussion of basic concepts. Electrophoresis 2, 1–11(1981).
- Hjelmeland L, Nebert D, Osborne J. Sulfobetaine derivatives of bile acids: nondenaturing surfactants for membrane biochemistry. Anal. Biochem. 130, 72–82 (1983).
- Chrambach A. The Practice of Quantitative Gel Electrophoresis. VCH, Weinheim, Germany, 1–195 (1985).
- Matt TD, Martinez-Yamout MA, Dyson HJ, Wright PE. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. Biochem. J. 381, 685–691 (2004).
- Nyborg JK, Peersen OB. That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators. Biochem. J. 381, E3–E4 (2004).
- Pidard D, Didry D, Kunicki TJ, Nurden AT. Temperature-dependent effects of EDTA on the membrane glycoprotein IIb-IIIa complex and platelet aggregability. Blood 67, 604–611 (1986).
- Schuchard MD, Mehigh RJ, Cockrill SL et al. Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by two-dimensional electrophoresis and mass spectrometry. BioTechniques 39, 239–247 (2005).
- Dias CL, Ala-Nissila T, Wong-ekkabut J, Vattulainen I, Grant M, Karttunen M. The hydrophobic effect and its role in cold denaturation. Cryobiology 60, 91–99 (2010).
- Freedman M, Rock G. Analysis of the products of cryoprecipitation: RiCoF is deficient in cryosupernatant plasma. Transfus. Apher. Sci. 43, 179–182 (2010).
- Privalov PL. Cold denaturation of proteins. Crit. Rev. Biochem. Mol. Biol. 25, 281–306 (1990).
- Roy I, Gupta MN. Freeze-drying of proteins: some emerging concerns. Biotechnol. Appl. Biochem. 39, 165–177 (2004).
- Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nature Reviews Drug Discov. 7, 21–39 (2008)
- Hiller A. Fast growth foreseen for protein therapeutics. Genetic Engineering News 29, 1–2 (2009).
- Baker MP, Reynolds HM, Lumicisi B, Bryson CJ. Immunogenicity of protein therapeutics: the key causes, consequences and challenges. Self. Nonself. 1, 314–322 (2010).
- Casadevall N, Nataf J, Viron B et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl. J. Med. 346, 469–475 (2002).
- Gershon SK, Luksenburg H, Cote TR, Braun MM. Pure red-cell aplasia and recombinant erythropoietin. N. Engl. J. Med. 346, 1584–1586 (2002).
- Hermeling S, Schellekens H, Crommelin D, Jiskoot W. Micelle-associated protein in epoetin formulations: a risk factor for immunogenicity? Pharm. Research Res. 20, 1903–1907 (2003).
- Trumpler S, Lohmann W, Meermann B, Buscher W, Sperling M, Uwe Karst U. Interaction of thimerosal with proteins: ethylmercury adduct formation of human serum albumin and lactoglobulin A. Metallomics 1, 87–91 (2009).
- Li Y, Yan XP, Chen C, Xia YL, Jiang Y. Human serum albumin-mercurial species interactions. J. Proteome Res. 6, 2277–2286 (2007).
- Takai K, Nakamura K, Toki T et al. Cell proliferation at 122°C and isotopically heavy CH4 production by a hyperthermophilic methanogen under high-pressure cultivation. Proc. Natl Acad. Sci. USA 105, 10949–10954 (2008).
- Sømme, L. Anhydrobiosis and cold tolerance in tardigrades. Eur. J. Entomol. 93, 349–357 (1996).
- Jönsson KI, Rabbow E, Schill RO, Harms-Ringdahl M, Rettberg P. Tardigrades survive exposure to space in low Earth orbit. Curr. Biol. 18(7), R729–R731 (2008).